Biosortia Pharma

Biosortia possesses the world's only capability to directly obtain highly sought-after, previously inaccessible drug-like molecules from microbiomes. Biosortia is actively engaged in researching novel drugs derived from microbiome chemistry for immuno-oncology and immunotherapy treatments.